Tel Aviv University researchers have developed a biological antibiotic derived from human monoclonal antibodies, as an alternative to traditional chemical antibiotics. The antibodies were taken from a recovered tuberculosis patient and were shown to kill TB bacteria – still a major global issue.
A healthier alternative to antibiotics
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.